|

|
Grant Sellar, DPhil
Discovery Translational Medicine
Wyeth Research
Phone: +44 (0) 1382 386360
Click
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
to email
Grant Sellar is the Oncology Translational Scientist within TMRC, having joined Wyeth in Feb 2007. Grant attained his B.Sc. and D.Phil at Oxford in 1986 and 1989 respectively. Following successful Post Doctoral positions at Harvard Medical School and Children’s Hospital, Boston; Department of Genetics, Trinity College Dublin; and MRC Human Genetics Unit, Edinburgh, Grant continued his research with an Oncology focus at the Cancer Research UK Centre in Edinburgh from 1997 until his current post. His work there, initiallly as a postdoctoral fellow and laterally as an independent Cancer Research UK scientist leading the ovarian cancer genetics group. Centred on the identification of OPCML as an ovarian cancer tumour suppressor gene primarily inactivated by CpG island methylation, extensive molecular profiling of an in vitro ovarian cancer cell line model expressing OPCML and detailed investigation of the tumour suppressor gene family in epithelial ovarian cancer and in normal ovarian biology. Grant was the recipient of prestigious Fellowships during his postdoctoral career having being awarded a Beit Memorial Fellowship for Medical Research and a Royal Society of Edinburgh/Caledonian Research Foundation Fellowship for his research in Trinity College, Dublin and MRC HGU, Edinburgh, respectively.
Selected Publications |